Mode II Compensation Failure in Endometriosis: A Formal Derivation of the Fibrotic Locking Threshold and Four Testable Predictions

preprint OA: green CC0
AI-generated summary by claude@2026-06, 2026-06-07

This paper derives a fibrotic locking threshold for endometriosis and proposes that antifibrotic therapy combined with wound-rate reduction is necessary and sufficient for non-redundant lesion recovery.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-07 · read from full text

The paper studies endometriosis as a formal example of Mode II compensation failure, using a cycle-averaged differential equation that incorporates two nonlinearities in fibrotic wound healing: self-amplifying ECM stiffening and resolution saturation, to explain why combining anti-injury approaches with antifibrotic therapy is non-redundant rather than merely additive. It derives a closed-form fibrotic locking threshold, ε* = ρ / [ρ + (√α + √(θ/ψ))²], and proves that both nonlinearities are required to produce bistability (neither alone suffices), with sufficiency established separately. It then presents four falsifiable predictions about how anti-platelet modulation of wound initiation, TGF-β3 restoration of resolution efficiency, and specific combination effects alter progression and recoverable lesion basins, and it includes a worked example addressing a separation of fibrotic benefit from fertility cost under the stated model. The paper does not state an explicit empirical limitation beyond being a formal framework tied to existing nonlinearities, and it preserves ovulation in its model because none of the interventions targets the hypothalamic–pituitary–ovarian axis. This paper is centrally about endometriosis — it derives a fibrotic “locking threshold” model to explain non-redundant combined antifibrotic and anti-injury strategies in endometriosis.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Endometriosis affects approximately 190 million women of reproductive age worldwide. Standard management — hormonal suppression, surgical excision, and combined oral contraceptives — controls symptoms but suppresses the reproductive axis, preventing pregnancy as a mechanism of treatment. The gynecological literature has empirically converged on combination approaches pairing injury-rate reduction with antifibrotic therapy, yet no formal account exists of why this combination is non-redundant — recovering lesions neither monotherapy can — rather than merely additive. This paper formalises endometriosis as a candidate instance of Mode II compensation failure: a regime in which a compensatory response (fibrotic wound healing) fires appropriately but its consolidation operator is misaligned toward a pathological attractor. From a cycle-averaged differential equation incorporating two documented nonlinearities — self-amplifying extracellular matrix (ECM) stiffening and resolution saturation — we derive a closed-form locking threshold ε* = ρ / [ρ + (√α + √(θ/ψ))²]: the misalignment above which, for a lesion at its current state, the fibrotic attractor is the only stable state. We prove that neither nonlinearity alone produces bistability; both are required (necessity), and sufficiency is established separately. Three testable predictions follow. (i) Anti-platelet modulation of wound-initiation rate raises ε*, slowing progression in early-stage disease. (ii) TGF-β3 restoration of resolution efficiency expands the recoverable basin. (iii) The combination is non-redundant and, in the fragile regime (ε* < 1/2), super-additive on the locking threshold — recovering lesions neither monotherapy reaches. As a structural consequence, because none of the intervention targets involves the hypothalamic–pituitary–ovarian axis, the combination preserves ovulation where hormonal suppression does not. A worked example illustrates how the ε* structure suggests separating dienogest's fibrotic benefit from its fertility cost via direct myofibroblast apoptosis induction combined with anti-platelet therapy. All predictions are falsifiable with existing or obtainable data. This paper is part of a program on formal frameworks for biological compensation. The companion framework paper is posted at DOI: 10.5281/zenodo.20515948.
Full text 2,852 characters · extracted from oa-doi-fallback · click to expand
Mode II Compensation Failure in Endometriosis: A Formal Derivation of the Fibrotic Locking Threshold and Four Testable Predictions Description Endometriosis affects approximately 190 million women of reproductive age worldwide. Standard management — hormonal suppression, surgical excision, and combined oral contraceptives — controls symptoms but suppresses the reproductive axis, preventing pregnancy as a mechanism of treatment. The gynecological literature has empirically converged on combination approaches pairing injury-rate reduction with antifibrotic therapy, yet no formal account exists of why this combination is non-redundant — recovering lesions neither monotherapy can — rather than merely additive. This paper formalises endometriosis as a candidate instance of Mode II compensation failure: a regime in which a compensatory response (fibrotic wound healing) fires appropriately but its consolidation operator is misaligned toward a pathological attractor. From a cycle-averaged differential equation incorporating two documented nonlinearities — self-amplifying extracellular matrix (ECM) stiffening and resolution saturation — we derive a closed-form locking threshold ε* = ρ / [ρ + (√α + √(θ/ψ))²]: the misalignment above which, for a lesion at its current state, the fibrotic attractor is the only stable state. We prove that neither nonlinearity alone produces bistability; both are required (necessity), and sufficiency is established separately. Three testable predictions follow. (i) Anti-platelet modulation of wound-initiation rate raises ε*, slowing progression in early-stage disease. (ii) TGF-β3 restoration of resolution efficiency expands the recoverable basin. (iii) The combination is non-redundant and, in the fragile regime (ε* < 1/2), super-additive on the locking threshold — recovering lesions neither monotherapy reaches. As a structural consequence, because none of the intervention targets involves the hypothalamic–pituitary–ovarian axis, the combination preserves ovulation where hormonal suppression does not. A worked example illustrates how the ε* structure suggests separating dienogest's fibrotic benefit from its fertility cost via direct myofibroblast apoptosis induction combined with anti-platelet therapy. All predictions are falsifiable with existing or obtainable data. This paper is part of a program on formal frameworks for biological compensation. The companion framework paper is posted at DOI: 10.5281/zenodo.20515948. Files Pan_ModeII_Endometriosis_v1.pdf Files (355.1 kB) | Name | Size | Download all | |---|---|---| | md5:4ff87685ff21e73ef1a94614d31e08d1 | 355.1 kB | Preview Download | Additional details Related works - Is part of - Preprint: 10.5281/zenodo.20515948 (DOI) - Preprint: 10.5281/zenodo.20441516 (DOI) - Preprint: 10.5281/zenodo.20102071 (DOI) Dates - Created - 2026-06-03

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

openalex
last seen: 2026-06-06T00:00:02.894732+00:00
License: CC0 · commercial use OK